Related Experiment Video

Updated: Jan 21, 2026

Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach
07:49

Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach

Published on: July 21, 2023

1.9K

Hidden in Heart Failure

Douglas Ewan Cannie1,2, Mohammed Majid Akhtar1,2, Perry Elliott1,2

  • 1University College London Institute for Cardiovascular Science London, UK.

European Cardiology
|July 31, 2019
PubMed

Insights

Diagnosing rare diseases in heart failure patients is crucial for improving quality of life and prognosis. Identifying specific causes enables tailored treatments beyond standard heart failure management.

Area of Science:

  • Cardiology
  • Genetics
  • Rare Diseases

Background:

  • Current diagnostic methods often miss rare diseases in heart failure patients.
  • Many idiopathic dilated cardiomyopathy and heart failure with preserved ejection fraction cases lack specific diagnoses.
  • Diagnostic delays negatively impact patient quality of life and prognosis.

Purpose of the Study:

  • To highlight the importance of identifying underlying causes of heart failure.
  • To advocate for tailored management strategies based on specific etiologies.
  • To emphasize the limitations of current diagnostic approaches for rare heart conditions.

Main Methods:

  • Review of current diagnostic challenges in heart failure.
  • Emphasis on the need for etiological investigation (genetic, inflammatory, infiltrative).
  • Discussion of the impact of diagnosis on patient outcomes.

Main Results:

  • A significant portion of heart failure patients remain undiagnosed for specific rare conditions.
  • Standard management protocols may not be sufficient for all heart failure subtypes.
  • Identifying specific causes can lead to personalized treatment plans.

Conclusions:

  • Accurate diagnosis of rare heart diseases in heart failure is essential.
  • Etiological identification allows for optimized, patient-specific treatment strategies.
  • Further research and improved diagnostic tools are needed for this population.

Keywords:
Heart failurecardiac amyloidosisdilated cardiomyopathygenetic cardiomyopathymyocarditisrare disease

More Related Videos

Gene Transfer for Ischemic Heart Failure in a Preclinical Model07:35

Gene Transfer for Ischemic Heart Failure in a Preclinical Model

Published on: May 15, 2011

13.3K
Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients03:47

Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients

Published on: July 12, 2024

1.1K

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
783
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.0K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
723
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
277
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
824
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
227